Arabic Arabic English English French French German German
dark

RedHill Biopharma Announces Settlement of Movantik® Patent Litigation with Apotex

RedHill Biopharma Ltd. today announced that RedHill Biopharma Inc., AstraZeneca AB and AstraZeneca Pharmaceuticals LP (“AstraZeneca”) and Nektar Therapeutics have entered into a settlement and license agreement with Apotex, Inc. resolving their patent litigation. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Adamas Announces Issuance of New Patents for GOCOVRI and ADS-4101

Next Post

Relief Announces Issuance of Shares from Authorized Capital as Approved by 2021 Annual General Meeting

Related Posts
Total
0
Share